收费全文 | 29175篇 |
免费 | 2350篇 |
国内免费 | 70篇 |
医药卫生 | 31595篇 |
2023年 | 233篇 |
2022年 | 190篇 |
2021年 | 893篇 |
2020年 | 564篇 |
2019年 | 875篇 |
2018年 | 941篇 |
2017年 | 637篇 |
2016年 | 668篇 |
2015年 | 815篇 |
2014年 | 1084篇 |
2013年 | 1392篇 |
2012年 | 2012篇 |
2011年 | 1973篇 |
2010年 | 1075篇 |
2009年 | 966篇 |
2008年 | 1590篇 |
2007年 | 1492篇 |
2006年 | 1408篇 |
2005年 | 1277篇 |
2004年 | 1187篇 |
2003年 | 1040篇 |
2002年 | 937篇 |
2001年 | 608篇 |
2000年 | 639篇 |
1999年 | 512篇 |
1998年 | 224篇 |
1997年 | 195篇 |
1996年 | 175篇 |
1995年 | 147篇 |
1994年 | 158篇 |
1993年 | 133篇 |
1992年 | 383篇 |
1991年 | 352篇 |
1990年 | 371篇 |
1989年 | 335篇 |
1988年 | 344篇 |
1987年 | 314篇 |
1986年 | 321篇 |
1985年 | 288篇 |
1984年 | 212篇 |
1983年 | 174篇 |
1979年 | 164篇 |
1978年 | 160篇 |
1977年 | 137篇 |
1975年 | 155篇 |
1974年 | 180篇 |
1973年 | 132篇 |
1972年 | 137篇 |
1971年 | 139篇 |
1970年 | 121篇 |
Areas covered: This review covers the mechanism of action, safety and efficacy of sacituzumab govitecan in patients with previously treated, metastatic TNBC. Additionally, efficacy data in other epithelial malignancies is included based on a PubMed search for ‘sacituzumab govitecan’ and ‘clinical trial’.
Expert opinion: Sacituzumab govitecan has promising anti-cancer activity in patients with metastatic TNBC previously treated with at least two prior lines of systemic therapy based on a single arm Phase I/II clinical trial. A confirmatory Phase III randomized clinical trial is ongoing. Sacituzumab govitecan has a manageable side effect profile, with the most common adverse events being nausea, neutropenia, and diarrhea. The activity of sacituzumab govitecan likely extends beyond TNBC with promising early efficacy data in many other epithelial cancers, including hormone receptor-positive breast cancer. 相似文献
Method: Thirty-two pediatric patients with stroke (Mage = 9.5 ± 2.7 years) and 32 demographically equivalent, healthy controls were tested on standardized measures of arithmetic, spelling, and intelligence. Executive functioning data were collected via standardized parent questionnaire.
Results: Relative to controls, stroke participants demonstrated significantly poorer functioning in math, spelling, metacognition, and behavioral-regulation. Pencil and paper arithmetic was particularly challenging for the stroke group, with 40% of patients reaching levels of clinical impairment. Hierarchical regression in stroke participants further revealed that metacognition was a robust predictor of academic deficits. Stroke occurring in later childhood and affecting cortical and subcortical brain regions also presented as potential clinical risk factors.
Conclusions: Children with stroke were especially vulnerable to math achievement deficits. Metacognition made a substantial contribution to academic achievement abilities among stroke patients, and results underscore the importance of early metacognitive skills in the completion of schoolwork. Results also emphasize that pediatric stroke patients are a heterogeneous group with regard to functioning and that there is value in examining standard score distributions of clinical participant samples. 相似文献